DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
The only GLP-1 telehealth scorecard that publishes raw sub-scores, not just a composite. Five weighted pillars, scored 0-10 each. Methodology is versioned so scores stay comparable over time.
Published cash-pay pricing, no hidden fees, flat-vs-escalating dose cost clarity, refund terms disclosed.
Brand-name vs compounded transparency, 503A/503B disclosure, named pharmacy partners, Certificate of Analysis availability.
Synchronous vs async MD consult, licensed-in-your-state verification, titration support, side-effect management protocol.
Onboarding speed, app/portal quality, provider response time, shipping reliability, cancellation friction.
State coverage breadth, insurance/PA handling, FSA/HSA support, drug-format options, supply reliability.
Initial published rubric: 5 pillars (pricing transparency 25%, pharmacy sourcing 25%, clinical oversight 20%, patient experience 15%, access & coverage 15%). Raw sub-scores published per provider for the first time in the GLP-1 review category.
Scores reflect editorial assessment against the published rubric, recalculated quarterly. Affiliate payout has no input into scoring. See how we make money.